Concepedia

Anna Pustilnik

AP

11

Publications

1.8K

Citations

11

H-Index

2014

Active since

Affiliations

Eli Lilly (United States)(Current)

Center Point

University of North Carolina at Chapel Hill

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Anna Pustilnik is an author at Eli Lilly (United States) specializing in molecular biology, antibody engineering, and medicine.

ORCID

Top concepts

Publications per year

2014–2022

11

Publications

11

The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · Science Translational Medicine · 2021 · 484 citations · Full text

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 452 citations · Full text

Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface

Steven M. Lewis, Xiufeng Wu, Anna Pustilnik et al. · Nature Biotechnology · 2014 · 237 citations

, , +13

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the <i>RB1</i> Tumor Suppressor Gene

Xueqian Gong, Jian Du, Stephen H. Parsons et al. · Cancer Discovery · 2018 · 220 citations

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection

Bryan E. Jones, Patricia Brown‐Augsburger, Kizzmekia S. Corbett et al. · 2020 · 173 citations · Full text

Rows per page

1–5 of 11